TJP1 and liver cancer: Previous studies have reported that the inhibition of ZO-1 restrains the proliferation and invasion of oral squamous carcinoma cells [67] while enhancing the cell proliferation and invasion capacity of endometrial cancer [68], pancreatic cancer [41], and liver cancer [69].